Does a correlation exist between delayed vaccination and a decreased vaccine confidence? by Virginia Reverte (9046494)

“…Vaccine Confidence Index (VCI) is an indicator to estimate confidence in vaccines, composed of simple dimensions about it and evaluated using a 5-point Likert scale. Objectives of this study, conducted in the Region of Murcia, Spain, were to determine which sociodemographic factors were associated with delayed administration in measles, mumps and rubella (MMR) vaccine, both first and second doses, and to evaluate if there were differences in parental vaccine confidence of children who were delayed on MMR vaccine schedule compare to vaccinated on time. …”

Supplemental Figure 4. Lamp2a Silencing Decreased and Lamp2a Overexpression Increased Luciferase protein levels in CMA-reporter Expressing H9c2 cells. by Rajeshwary Ghosh (9764078)

PSMα3N22Y has decreased chemotactic activity toward human neutrophils. by Gordon Y. C. Cheung (337723)

Reduced expression of Tks5 leads to decreased growth of tumor cells <i>in vitro</i> and <i>in vivo</i>. by Barbara Blouw (715467)

Sis1-S49V, does not show decreased steady-state levels when expressed in Sc37 [PSI⁺] strain. by Melanie Y. Pullen (8933987)

The T37A substitution increases both H5N6 M1 protein stability and H5N6 viral replication in mammals. by Chenxi Wang (284364)

Subjects:

Finer analysis of decreasing synaptic pruning rates. by Saket Navlakha (142449)

Sign-tracking (ST)–Goal-tracking (GT) score for day 5. by Silvia Fuentes (4759686)

Purine nucleotides are decreased in long-term hypoxia. by Emily B. Cohen (9106088)

Decreased expression of RRIowa_1520 by <i>R. rickettsii</i> Iowa. by Adam M. Nock (16715671)

High Levels of SOX5 Decrease Proliferative Capacity of Human B Cells, but Permit Plasmablast Differentiation by Mirzokhid Rakhmanov (580449)

2D and 3D AFM micrographs of fabricated samples (a) 5LZCM (b) 10LZCM (c) 15LZCM. by Md. Abu Daud (21485629)

Specificity of ChR2-YFP expression in DRN 5-HT neurons and efficiency of photostimulation <i>in vitro</i>. by Guillaume P. Dugué (620333)

FTY720 decreases cerebral lymphocyte invasion. by Arthur Liesz (349478)

A Peptide Mimetic of 5-Acetylneuraminic Acid-Galactose Binds with High Avidity to Siglecs and NKG2D by Laura L. Eggink (760403)

“…In addition, the peptide bound the receptor NKG2D, which contains a lectin-like domain that binds Neu5Ac(α2,3)Gal. …”

Laquinimod prevents EAE and decreases encephalitogenicity of T cells. by Ulf Schulze-Topphoff (174453)

“…Representative FACS staining is shown including quantification (n = 4–5 mice per group). (E) Laquinimod decreases pathogenic potential of T cells. …”

Cediranib therapy decreases tumor blood volume. by Christian T. Farrar (355177)

“…<p>(left) After 2–3 days of treatment, a statistically significant (p<0.01) difference in the rCBV (±SEM) was observed between cediranib and control groups with a 16.5±2.2% decrease for cediranib treated animals and a 14.1±2.3% increase for control animals. …”

Adenosine decreases the amplitude of evoked AMPA EPSCs via activation of A₁ ARs without altering that of the evoked IPSCs recorded from layer III pyramidal neurons in th... by Shouping Wang (402959)

“…<b>F,</b> Bath application of dipyridamole (1 µM), an adenosine transporter inhibitor, significantly reduced the evoked EPSCs (n = 10, p<0.001, paired t-test) suggesting that endogenously released adenosine decreases AMPA EPSCs. <b>G,</b> Prior application of DPCPX, an A₁ AR blocker, blocked dipyridamole-induced depression of AMPA EPSCs (n = 5, p = 0.85 vs. baseline, paired t-test) suggesting that the inhibitory effect of dipyridamole is mediated via activation of A₁ ARs. …”

Vi expression decreases antibody and complement binding to <i>Salmonella</i> in the absence of specific antibodies. by Peter J. Hart (503558)

B2 decreases glycolytic intermediates in cells. by Craig Eyster (392633)

“…<b>(C)</b> Heatmap of targeted metabolomic data. Each column is a separate biological replicate (n = 5). The box indicates the clustering of decreased downstream glycolytic intermediates in B2-treated cells. …”